Skip to main content
. Author manuscript; available in PMC: 2021 Dec 28.
Published in final edited form as: J Clin Epidemiol. 2021 Sep 3;140:101–110. doi: 10.1016/j.jclinepi.2021.09.001

Table 4:

Percentage with viral load monitoring before and after national Treat-All policy adoption by country.

Lesotho Malawi Mozambique South Africa Zambia Zimbabwe

Patients 1,309 (100%) 9,915 (100%) 7,295 (100%) 15,616 (100%) 109,536 (100%) 5,975 (100%)
 before Treat-All 626 (48%) 6,071 (61%) 3,421 (47%) 8,316 (53%) 56,951 (52%) 3,349 (56%)
 after Treat-All 683 (52%) 3,844 (39%) 3,874 (53%) 7,300 (47%) 52,585 (48%) 2,626 (44%)

Risk difference at threshold* −1.2 0.6 2.6 4.0 0.7 0.4
 (95% CI) (−5.4, 3.1) (−4.7, 6.0) (−0.5, 5.7) (−0.9, 8.8) (−0.9, 2.2) (−3.2, 4.0)
 p-value 0.589 0.815 0.094 0.108 0.400 0.809
 IK bandwidth (days) 316 113 123 153 149 310
 patients within bandwidth 576 2,519 1,365 4,225 28,068 2,981
Treatment Effect Derivative 0.001 0.024 −0.036 0.041 −0.031 −0.041
 (95% CI) (−0.021, 0.024) (−0.061, 0.110) (−0.077, 0.0048) (−0.012, 0.095) (−0.048, −0.013) (−0.060, −0.024)
 p-value 0.893 0.581 0.083 0.130 0.001 <0.001

Predicted outcomes at threshold
 just before Treat-All 2.5 8.9 1.5 75.6 12.0 8.4
  (95% CI) (−1.0, 6.0) (4.6, 13.2) (0.2, 2.8) (72.0, 79.2) (11.0, 13.1) (6.1, 10.7)
 just after Treat-All 1.3 9.5 4.1 79.6 12.7 8.8
  (95% CI) (−1.1, 3.8) (6.4, 12.7) (1.3, 7.0) (76.4, 82.7) (11.6, 13.8) (6.0, 11.6)
 relative change −48.0% 6.7% 173.3% 5.2% 5.8% 4.8%

Slopes before and after Treat-All
 before Treat-All (95% CI) 0.0 (−0.2, 0.2) 0.8 (0.7, 0.8) 0.1 (0.1, 0.2) 0.2 (−0.0, 0.3) 0.4 (0.4, 0.4) 0.4 (0.3, 0.4)
 after Treat-All (95% CI) −0.1 (−0.2, 0.0) 1.4 (1.1, 1.7) 0.2 (0.1, 0.3) −0.1 (−0.3, 0.1) 1.0 (0.9, 1.1) 0.2 (0.0, 0.4)
 p-value 1.000 0.030 0.034 <0.001 0.012 0.069

Abbreviation: CI, confidence interval.

*

Risk differences at the national Treat-All policy adoption threshold are from regression discontinuity analyses using Imbens-Kalyanaraman (IK) bandwidths derived from all data available within two years before and after the threshold to estimate the difference in local linear predictions. The bandwidth defines the area on each side of the threshold where the relationship between antiretroviral therapy (ART) start and viral load monitoring is assumed to be linear in local linear regression models.

Slope comparison is from separate linear regression models comparing the percentage point change per month before and after Treat-All using all data available within two years before and after national Treat-All adoption.